Swerdlow SH, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90.

CAS  Article  Google Scholar 

Abe N, Fujieda Y. Chronic active Epstein-Barr virus infection. Blood. 2020;136(18):2090.

CAS  Article  Google Scholar 

Leong MML, Lung ML. The impact of Epstein-Barr virus infection on epigenetic regulation of host cell gene expression in Epithelial and Lymphocytic Malignancies. Front Oncol. 2021;11:629780.

Article  Google Scholar 

Lin C, et al. Plasma Epstein-Barr virus MicroRNA BART8-3p as a diagnostic and prognostic biomarker in nasopharyngeal carcinoma. Oncologist. 2022;27(4):e340–9.

Article  Google Scholar 

Habeeb R, Al Hafar L, Monem F. EBV plasma Epstein-Barr Virus (EBV) DNA as a biomarker for diagnosis of EBV-positive Hodgkin lymphoma in Syria. J Infect Dev Ctries. 2021;15(12):1917–22.

CAS  Article  Google Scholar 

Pramanik R, et al. Cell-free EBV DNA as a biomarker during clinical management of nasopharyngeal carcinoma in a nonendemic region. J Med Virol. 2022;94(2):720–8.

CAS  Article  Google Scholar 

Xian RR, et al. Plasma EBV DNA: A promising diagnostic marker for endemic Burkitt lymphoma. Front Oncol. 2021;11:804083.

Article  Google Scholar 

Montgomery ND, et al. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi. Cancer Med. 2020;9(2):552–61.

CAS  Article  Google Scholar 

van Doesum JA, et al. Extranodal natural killer/T-cell lymphoma, nasal type: Diagnosis and treatment. Hemasphere. 2021;5(2):e523.

Article  Google Scholar 

Kostadinova T, et al. Detection of EBV DNA in Non-Hodgkin Lymphoma patients in Bulgaria. Indian J Hematol Blood Transfus. 2019;35(3):465–70.

Article  Google Scholar 

Liu Y, et al. Clinical features of intestinal Ulcers complicated by Epstein-Barr Virus infection: Importance of active infection. Dis Markers. 2021;2021:6627620.

PubMed  PubMed Central  Google Scholar 

Beltran BE, et al. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(4):435–45.

CAS  Article  Google Scholar 

Gao X, et al. Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis. PLoS ONE. 2018;13(6):e0199398.

Article  Google Scholar 

Song J, et al. Utility of Epstein-Barr Viral load in blood for diagnosis and predicting prognosis of lymphoma: A comparison with Epstein-Barr Virus-Encoded RNA in Situ Hybridization. J Mol Diagn. 2022;24(9):977–91.

CAS  Article  Google Scholar 

Eladl AE, et al. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Cancer Med. 2020;9(2):678–88.

CAS  Article  Google Scholar 

Xu S, et al. Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area. Therap Adv Gastroenterol. 2020;13:1756284820930124.

CAS  Article  Google Scholar 

Okamoto A, et al. The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients. Hematol Oncol. 2017;35(1):87–93.

CAS  Article  Google Scholar 

Kim JH, et al. Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma. Sci Rep. 2021;11(1):2880.

CAS  Article  Google Scholar 

Shen Z, et al. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group. Int J Cancer. 2022;150(2):327–34.

CAS  Article  Google Scholar 

Kanakry JA, et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127(16):2007–17.

CAS  Article  Google Scholar 

Kawano T, et al. Clinicopathologic analysis of primary adrenal diffuse large B-Cell Lymphoma: A reappraisal of 23 Japanese patients based on EBV association and PD-L1 expression in Tumor cells. Am J Surg Pathol. 2021;45(12):1606–15.

Article  Google Scholar 

Li YJ, et al. HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases. Blood Res. 2020;55(1):49–56.

Article  Google Scholar 

Koh YW, et al. Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin’s lymphoma. Hematol Oncol. 2018;36(1):182–8.

CAS  Article  Google Scholar 

Tse E, Kwong YL. How I treat NK/T-cell lymphomas. Blood. 2013;121(25):4997–5005.

CAS  Article  Google Scholar 

Gruhne B, Sompallae R, Masucci MG. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene. 2009;28(45):3997–4008.

CAS  Article  Google Scholar 

Huang YC, et al. Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients’ survival. Blood. 2016;128(12):1578–89.

CAS  Article  Google Scholar 

Ferrajoli A, et al. Epstein-Barr Virus MicroRNAs are expressed in patients with Chronic Lymphocytic Leukemia and correlate with overall survival. EBioMedicine. 2015;2(6):572–82.

Article  Google Scholar 

Wang L, et al. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase. Oncotarget. 2015;6(30):30317–26.

Article  Google Scholar 

He SS, et al. Circulating plasma Epstein-Barr Virus DNA load during the follow-up periods predicts recurrence and metastasis in Nasopharyngeal Carcinoma. Cancer J. 2022;28(2):85–92.

CAS  Article  Google Scholar 

Gihbid A, et al. Circulating cell-free epstein-barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer. 2021;16(1):15.

CAS  Article  Google Scholar 

Zhao FP, et al. Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma. Oncol Lett. 2015;10(5):2888–94.

Article  Google Scholar 

Liang JH, et al. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma. Clin Microbiol Infect. 2015;21(6):596–602.

CAS  Article  Google Scholar 

Haverkos BM, et al. Increased levels of plasma Epstein Barr Virus DNA identify a poor-risk subset of patients with advanced stage cutaneous T-cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2016;16:S181–90.

Article  Google Scholar 

Hwang J, Suh CH, Won Kim K, Kim HS, Armand P, Huang RY, Guenette JP. The incidence of Epstein-Barr Virus-positive diffuse large B-Cell Lymphoma: A systematic review and meta-analysis. Cancers. 2021;13(8):1785.

Article  Google Scholar